Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR / PCA Shareholdings

8 Dec 2017 17:34

RNS Number : 8840Y
ThinkSmart Limited
08 December 2017
 

8 December 2017

 

 

ThinkSmart Limited

("ThinkSmart" or the "Company" and together with its subsidiaries the "Group")

 

PDMR / PCA Shareholdings

 

 

ThinkSmart Limited (AIM: TSL), was notified on 8 December 2017 that Ned Montarello, Executive Chairman of the Group, received 250,000 ordinary shares of no present value each in the Company ("Ordinary Shares") on 8 December 2017 (the "Transaction"), from the trustee of ThinkSmart's loan funded share plan ("Loan Funded Share Plan"). Prior to the Transaction, the trustee had been holding the Ordinary Shares on trust for Mr Montarello and the Transaction has resulted in Mr Montarello (as opposed to the trustee) being the registered holder of the Ordinary Shares. Mr Montarello received the shares in return for repaying his existing loan on the vested Ordinary Shares issued under the Company's 2012 Loan Funded Share Plan, as stated in the Company's admission document. Vesting of the loan funded shares, which occurred on 10 August 2015, was subject to certain performance criteria achieved prior to the Company's admission to AIM.

 

In addition, in accordance with the Loan Funded Share Plan, the Company will buy-back and cancel 750,000 and 500,000 Ordinary Shares which were issued to the trustee of ThinkSmart's Loan Funded Share Plan on 4 July 2013 and 18 September 2014 respectively to hold on trust for Mr Montarello subject to performance criteria. The 750,000 and 500,000 Ordinary Shares failed to vest due to not meeting the required performance criteria and so will be bought back, at nil cost to the Company, and cancelled shortly reducing both Mr Montarello's holding in the Company and also the number of Ordinary Shares in issue.

 

Post the Transaction and the cancellation of the 1,250,000 Ordinary Shares that did not vest, Mr Montarello's total holding will comprise of 29,061,036 Ordinary Shares (including 250,000 loan funded shares issued on 4 July 2013 which vested prior to admission to AIM but which remain subject to a loan), representing 27.88% of the Company's issued share capital of 104,228,744 (following the cancellation of the 1,250,000) Ordinary Shares.

 

A PDMR dealing notification will be made in due course following the completion of the buyback and cancellation of the 1,250,000 shares.

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1.

Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

Mr Ned Montarello

2.

Reason for the notification

a)

Position / status

PDMR (Executive Chairman)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ThinkSmart Limited

b)

Legal Entity Identifier

213800ZBZQVXHDZHET73

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of NPV each in the Company

AU000XINEAE8

b)

Nature of the transaction

Transfer of legal title from ThinkSmart LTI Pty Ltd ("trustee") to Ned Montarello for vested Ordinary Shares issued under the ThinkSmart Limited 2012 Loan Funded Share Plan and previously held on trust by trustee for Ned Montarello

c)

Price(s) and volume(s)

Price(s)

Volume(s)

A$0.1923

 

250,000 Ordinary Shares

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

250,000 Ordinary Shares

A$0.1923 per Ordinary Share

 

e)

Date of the transaction(s)

8 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

For further information please contact:

ThinkSmart Limited

Via Instinctif Partners

Ned Montarello

Canaccord Genuity (Nominated Adviser, Financial Adviser and Joint Broker)

+44 (0)20 7523 8350

 

Sunil Duggal

David Tyrrell

Andrew Buchanan

Richard Andrews

Peel Hunt LLP (Joint Broker)

+44 (0) 20 7418 8900

Charles Batten

Guy Wiehahn

Rishi Shah

Instinctif Partners

+44 (0)20 7457 2020

Giles Stewart

Rui Videira

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKFDNOBDDKBK
Date   Source Headline
22nd Dec 20164:42 pmRNSBuy-back class ruling
22nd Dec 20163:05 pmRNSGrant of LTIP Awards
16th Dec 20168:02 amRNSAppointment of Joint Corporate Broker
15th Dec 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Dec 20165:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Dec 20167:00 amRNSChange in ISIN and SEDOL
2nd Dec 20168:06 amRNSAdmission to AIM and First Day of Dealings
21st Apr 20082:47 pmRNSIssue of Equity-TissueScience
8th Apr 20082:26 pmRNSTissue Science Equity Issue
2nd Apr 20084:44 pmRNSTissue Science Laboratories
2nd Apr 200812:18 pmRNSTissue Science Laboratories
1st Apr 20087:57 amRNSEPT Disclosure
28th Mar 20083:26 pmRNSHolding(s) in Company
28th Mar 200812:02 pmRNSHolding(s) in Company
28th Mar 20087:02 amRNSRule 8.1- Tissue Science Lab
27th Mar 200811:41 amRNSHolding(s) in Company
27th Mar 20089:47 amRNSRule 8.1 - Tissue Science Lab
25th Mar 20087:01 amRNSRule 8.1- Tissue Science Lab.
19th Mar 200811:29 amRNSHolding(s) in Company
19th Mar 20089:29 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:25 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:22 amRNSRule 8.1- Tissue Science Lab.
14th Mar 20084:31 pmRNSRule 8.3- Tissue Science
14th Mar 20082:21 pmRNSRule 8.3- Tissue Science
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:15 amRNSRule 8.3- Tissue Science
14th Mar 20088:09 amRNSRule 8.1- Tissue Science Lab
13th Mar 20082:26 pmBUSRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20082:05 pmRNSRule 8.1- Tissue Science Lab.
13th Mar 20081:07 pmRNSEPT Disclosure-Amend
13th Mar 200811:05 amPRNRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20088:36 amRNSEPT Disclosure
13th Mar 20087:00 amRNSRule 8.1- Tissue Science Lab.
12th Mar 20083:55 pmRNSOffer Document Posted
12th Mar 20087:01 amRNSOffer for Tissue Science Lab.
12th Mar 20087:01 amRNSFinal Results & Cash Offer
17th Jan 20087:00 amRNSPositive Study Results
12th Nov 200710:47 amRNSHolding(s) in Company
7th Nov 20074:22 pmRNSHolding(s) in Company
28th Sep 20077:02 amRNSInterim Results
10th Sep 20077:01 amRNSNotice of Results
28th Aug 200712:26 pmRNSHolding(s) in Company
17th Aug 20073:28 pmRNSAIM Rule 26 Compliance
6th Jul 20072:25 pmRNSResult of AGM
6th Jul 20077:00 amRNSPre-close Trading Statement
29th Jun 20074:00 pmRNSTotal Voting Rights
14th Jun 20077:00 amRNSNotice of AGM
31st May 200712:00 pmRNSExercising of Options
16th Apr 20077:01 amRNSR&D Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.